MedTrace Logo

Smoking Cessation in Hospitalized Smokers

NCT01289275 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1270

Last updated 2020-02-13

Study results available
· View outcomes & findings →

Summary

When smokers are hospitalized they quit smoking, either voluntarily or involuntarily. Most of them, however, go back to smoking soon after discharge. This study will test an innovative approach which includes dispensing nicotine patches at discharge, providing proactive telephone counseling post discharge, or giving a combination of the two. The interventions are aimed at increasing the long term quit rate of these patients.

The specific aims of the study are to demonstrate the effects of two interventions, dispensing nicotine patches at discharge and providing proactive telephone counseling soon after discharge, on 12-month quit rates of hospitalized smokers in a 2 x 2 factorial design.

Conditions

  • Smoking Cessation

Interventions

DRUG

Nicotine Patches

Subjects randomized into the patch condition will receive 8 weeks of nicotine patches at discharge. The kit will contain 4 weeks of 21mg patches, 2 weeks of 14mg, and 2 weeks of 7mg.

BEHAVIORAL

Telephone Counseling

Up to 5 proactive counseling sessions from California Smokers' Helpline.

BEHAVIORAL

Brief Hospital Counseling

All subjects receive bedside counseling either from Respiratory Therapists or nurses according to the hospital's particular practices.

Sponsors & Collaborators

Principal Investigators

  • Shu-Hong Zhu, Ph.D. · UCSD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01289275 on ClinicalTrials.gov